| # | Drug | Count |
|---|---|---|
| 0 | DABRAFENIB | 57 |
| 1 | PEMBROLIZUMAB | 56 |
| 2 | TRAMETINIB | 54 |
| 3 | NIVOLUMAB | 36 |
| 4 | TALIMOGENE LAHERPAREPVEC | 30 |
| 5 | PREDNISONE | 22 |
| 6 | IPILIMUMAB | 21 |
| 7 | SILDENAFIL CITRATE | 18 |
| 8 | INFLIXIMAB | 16 |
| 9 | METHOTREXATE SODIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALIMOGENE LAHERPAREPVEC | 30 | 0.0189 |
| 1 | AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE | 1 | 0.0039 |
| 2 | LIFILEUCEL | 1 | 0.0035 |
| 3 | DABRAFENIB | 57 | 0.0027 |
| 4 | TRAMETINIB | 54 | 0.0022 |
| 5 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 6 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONE | 1 | 0.0018 |
| 7 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 8 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE | 1 | 0.0017 |
| 9 | ALDESLEUKIN | 2 | 0.0016 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 90 | 0.0009 |
| 3 | Photoenhancer [EPC] | 2 | 0.0005 |
| 4 | Actinomycin [EPC] | 1 | 0.0005 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 21 | 0.0004 |
| 6 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 8 | Interleukin-23 Antagonist [EPC] | 16 | 0.0002 |
| 9 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |